Wysong A. Squamous-cell carcinoma of the skin. N Engl J Med. 2023;388(24):2262–73.

CAS  PubMed  Google Scholar 

Leibovitch I, Huilgol S, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I Experience over 10 years. J Am Acad Dermatol. 2005;53(2):253–60. https://doi.org/10.1016/j.jaad.2005.02.059.

Article  PubMed  Google Scholar 

Veness MJ, Porceddu S, Palme CE, Morgan GJ. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29(7):621–31. https://doi.org/10.1002/hed.20576.

Article  PubMed  Google Scholar 

Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(s61):1–6. https://doi.org/10.1046/j.1365-2133.146.s61.2.x.

Article  PubMed  Google Scholar 

Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 1992;26(3):467–84. https://doi.org/10.1016/0190-9622(92)70074-p.

Article  CAS  PubMed  Google Scholar 

Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: management of advanced and high-stage tumors. J Am Acad Dermatol. 2018;78:249–61. https://doi.org/10.1016/j.jaad.2017.08.058.

Article  PubMed  Google Scholar 

Jubran J, Sengelmann RD. High-risk squamous cell carcinoma and its impact on a 62-year-old male surgeon. BMJ Case Rep. 2019;12(8):e229940. https://doi.org/10.1136/bcr-2019-229940.

Article  PubMed  PubMed Central  Google Scholar 

Gross ND, Miller DM, Khushalani NI, et al. Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma. N Engl J Med. 2022;387(17):1557–68. https://doi.org/10.1056/NEJMoa2209813.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gross ND, Miller DM, Khushalani NI, et al. Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study. Lancet Oncol. 2023;24(11):1196–205. https://doi.org/10.1016/S1470-2045(23)00459-X.

Article  CAS  PubMed  Google Scholar 

Ascierto P, Bossi P, Mandalà M, et al. NEO-CESQ study: Neoadjuvant plus adjuvant treatment with cemiplimab in surgically resectable, high risk stage III/­IV (M0) cutaneous squamous cell carcinoma. J Clin Oncol. 2023;41(Suppl 16):9576. https://doi.org/10.1200/JCO.2023.41.16_suppl.9576.

Article  Google Scholar 

Conti M, Morciano F, Bufi E, et al. Surgical planning after neoadjuvant treatment in breast cancer: a multimodality imaging-based approach focused on MRI. Cancers. 2023;15(5):1439. https://doi.org/10.3390/cancers15051439.

Article  PubMed  PubMed Central  Google Scholar 

Sweeny L, Zimmerman T, Carroll WR, Schmalbach CE, Day KE, Rosenthal EL. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection. Otolaryngol Head Neck Surg. 2014;150:610–7. https://doi.org/10.1177/0194599814520686.

Article  PubMed  Google Scholar 

Chabrillac E, Talawdekar A, Garikipati S, et al. A single centre’s experience of 23 cases of total rhinectomy for the treatment of squamous cell carcinoma involving the nasal vestibule. Eur Arch Otorhinolaryngol. 2022;279:2069–75. https://doi.org/10.1007/s00405-021-06972-6.

Article  PubMed  Google Scholar 

Golshan M, Loibl S, Wong SM, et al. Breast conservation after neoadjuvant chemotherapy for triple-negative breast cancer: surgical results from the BrighTNess randomized clinical trial. JAMA Surg. 2020;155(3):195410. https://doi.org/10.1001/jamasurg.2019.5410.

Article  Google Scholar 

Carlson RW, Allred DC, Anderson BO, et al. National Comprehensive Cancer Network. Invasive breast cancer. J Natl Compr Canc Netw. 2011;9(2):136–222. https://doi.org/10.6004/jnccn.2011.0016.

Article  CAS  PubMed  Google Scholar 

Arlow RL, Paddock LE, Niu X, et al. Breast-conservation therapy after neoadjuvant chemotherapy does not compromise 10-year breast cancer-specific mortality. Am J Clin Oncol. 2018;41(12):1246–51. https://doi.org/10.1097/COC.0000000000000456.

Article  PubMed  PubMed Central  Google Scholar 

Song YC, Huang Z, Fang H, et al. Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy. Front Oncol. 2023;13:1178230. https://doi.org/10.3389/fonc.2023.1178230.

Article  PubMed  PubMed Central  Google Scholar 

Rozeman EA, et al. Neo-adjuvant ipilimumab plus nivolumab in palpable stage III melanoma (OpACIN-neo): a multicentre, open-label, randomized, phase 2 trial. Lancet Oncol. 2019;20(7):948–60. https://doi.org/10.1016/S1470-2045(19)30219-7.

Article  CAS  PubMed  Google Scholar 

Menzies AM, et al. Pathological response and surgical outcomes in the PRADO trial of personalized neoadjuvant therapy in stage III melanoma. Nat Med. 2021;27(7):1229–34. https://doi.org/10.1038/s41591-021-01342-3.

Article  Google Scholar 

Blank CU, et al. NADINA: a randomized phase 3 trial of neoadjuvant vs. adjuvant immunotherapy in macroscopic stage III melanoma. Presented at ASCO 2024. Abstract #LBA9501

Amaria RN, et al. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. N Engl J Med. 2023;388:111–21. https://doi.org/10.1056/NEJMoa2211430.

Article  Google Scholar 

Baba N, Nakamura Y, Kato H, et al. Survival analysis between narrower surgical margins and guideline-recommended margins for excision of cutaneous squamous cell carcinoma: a multicenter, retrospective study of 1,204 Japanese cases. J Clin Oncol. 2020;10063:10063. https://doi.org/10.1200/JCO.2020.38.15_suppl.10063.

Article  Google Scholar 

Schwartz LH, Litière S, De Vries E, et al. RECIST 11—Update and clarification: from the RECIST committee. Eur J Cancer. 2016;62:132–7. https://doi.org/10.1016/j.ejca.2016.03.081.

Article  PubMed  PubMed Central  Google Scholar 

Amin, M. B., Greene, F. L., Edge, S. B., et al. 2017 The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93-99 https://doi.org/10.3322/caac.21388.

Stratigos AJ, Garbe C, Dessinioti C, et al. European Consensus-Based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: part 2. Treatment-Update 2023. Eur J Cancer (Oxford, England). 2023;193:113252. https://doi.org/10.1016/j.ejca.2023.113252.

Article  CAS  Google Scholar 

Khan AA, Potter M, Cubitt JJ, et al. Guidelines for the excision of cutaneous squamous cell cancers in the United Kingdom: the best cut is the deepest. J Plast Reconstr Aesthet Surg. 2013;66(4):467–71. https://doi.org/10.1016/j.bjps.2012.12.016.

Article  CAS  PubMed  Google Scholar 

Kim EY, Ruiz ES, DeSimone MS, et al. Neoadjuvant-intent immunotherapy in advanced, resectable cutaneous squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2024;150(5):414–20. https://doi.org/10.1001/jamaoto.2024.0259.

Article  PubMed  PubMed Central  Google Scholar 

Schmults CD, Blitzblau R, Aasi SZ, et al. Basal cell skin cancer, Version 22024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21(11):1181–203. https://doi.org/10.6004/jnccn.2023.0056.

Article  CAS  PubMed  Google Scholar